The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions
- 1.1k Downloads
Although the impact of stigma has been highlighted for epileptic populations, the experiences of people living with other neurological conditions have been less studied.
In order to promote research on stigma among people with neurological conditions, we sought to develop and psychometrically validate an eight-item questionnaire measuring internalised and enacted stigma experienced by people with epilepsy, multiple sclerosis (MS), Parkinson’s disease (PD), stroke and amyotrophic lateral sclerosis (ALS).
We used item response theory methodologies to select items and field tested our items with 587 participants from eight academic medical centres across the USA.
We conducted exploratory and confirmatory factor analysis as well as examined the scale’s reliability and validity. In addition, we conducted an analysis of variance test to examine mean total score differences across the five neurological conditions. Data from people across conditions revealed that the shortened instrument conformed to an essentially unidimensional model of multifaceted stigma as a one-factor questionnaire with correlated residuals on a pair of items that distinctly measured internalised stigma.
Preliminary evidence suggests that the Stigma Scale for Chronic Illness 8-item version fits a unidimensional model, which assesses enacted and internalised stigma, and has adequate internal consistency/reliability and validity in relation to psychological distress and patient performance. Our results suggest fairly low stigma for neurological populations. In addition, our results suggest that stigma may be more severe for patients with ALS relative to those with MS and PD. In the future, the SSCI-8 scale could be used practically in clinic settings to examine stigma without the patient burden associated with lengthier scales.
KeywordsNeurological disorder Epilepsy Quality of life Stigma Measurement
The authors would like to thank two anonymous reviewers for their critical review of this study and Betsy J. Feldman, Ph.D. for her technical assistance with the statistical analysis for this project. This study was support by a contract from the National Institute for Neurological Disorders and Stroke number HHSN265200423601C Cella (PI) and K23 MH 084551 PI: Rao.
- 3.Dallmeijer AJ, de Groot V, Roorda LD, Schepers VPM, Lindeman E, van den Berg LH, Beelen A, Dekker J, Fupro Study Group. Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis, and amyotrophic lateral sclerosis: a study using Rasch analysis. J Rehab Med. 2007;39:163–9.CrossRefGoogle Scholar
- 5.Heilman KM, Valenstein E, editors. Clinical neuropsychology. New York: Oxford University Press; 2004.Google Scholar
- 9.Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon and Schuster; 1963.Google Scholar
- 12.Hill M. Overcoming the stigma of epilepsy. Neurol Asia. 2010;15:S21–4.Google Scholar
- 36.Rao D, Andrasik M, Acharya X, Simoni J. Internalized stigma among African Americans living with HIV: preliminary scale development based on qualitative data. In: Liamputtong P, editor. Stigma, discrimination, and living with HIV/AIDS: a cross-cultural perspective. Springer; 2012 (in press).Google Scholar
- 38.Rao D, Feldman B, Fredericksen R, Crane P, Simoni J, Kitahata M, Crane H. A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS Behav. 2011. doi: 10.1007/s10461-011-9915-0.
- 42.Hambleton RR, Swaminathan H, Rogers HJ. Fundamentals of item response theory. Newbury Park: Sage; 1991.Google Scholar
- 43.Cella D, Chang C-H. Response to Hays et al. and McHorney and Cohen: A discussion of item response theory and its applications in health status assessment. Med Caer. 2000;38:S66–72.Google Scholar
- 46.Reeve B, Fayers P. Applying item response theory modeling for evaluating questionnaire item and scale properties. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials: methods of practice. 2nd ed. USA: Oxford University Press; 2005. p. 55–73.Google Scholar
- 47.National Institute of Neurological Disorders and Stroke (NINDS). User manual for the quality of life in neurological disordres (Neuro-QOL) measures, version 1.0. September 2010.Google Scholar
- 48.Mplus version 6.0. [Computer software]. Los Angeles: Muthén Muthén.Google Scholar
- 49.Gershon RC, Lai JS, Bode R, Choi S, Moy C, Bleck T, et al. NeuroQOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2011. doi: 10.1007/s11136-011-9958-8.